Smith & Nephew
REMEDI commenced a new partnership with global medical technology company Smith & Nephew in October 2007.
An investment of €6 million, supported by the IDA, will fund research for four years working to develop new therapies to treat painful musculoskeletal conditions like Osteoarthritis
To access the Smith & Nephew UK homepage, click here
